Troutman Pepper advised Larimar Therapeutics, Inc. on the deal.Larimar Therapeutics, Inc. (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, has…
Larimar Therapeutics’ $80.5 Million Shares Offering
![](https://globallegalchronicle.com/wp-content/uploads/2022/10/larimar-therapeutics-80-5-million-shares-offering_633bcc9f162f0.jpeg)